Table 3.
M. avium | ||||
---|---|---|---|---|
CFU submitted to DNA extraction and qPCR | Average number ± SEM of 16S rRNA targets amplified in presence (+) or absence (-) of human DNAa (sensitivity based on CFU) | Amplification efficiency in presence of human DNA (%)b | Human:MAC genome ratioc,d | |
- | + | |||
270 | 206±61 (76%) | 131±77 (49%) | 64% | 31,100 |
2,700 | 2,105±128 (78%) | 1,453±112 (54%) | 69% | 3,500 |
27,000 | 53,600±330 (199%) | 39,430±377 (146%) | 74% | 190 |
270,000 | 441,264±16,910 (163%) | 472,860±9,259 (175%) | 107% | 30 |
Data shown for number of M. avium targets in the 60 μl final volume, estimated from results obtained from a 5 μl specimen submitted to qPCR
Percentage of M. avium targets amplified when human DNA is in background, compared to no human DNA background as reference
Calculations based on estimate that there is one genome for every 16S rRNA for M. avium, or ApoB gene for human
Data rounded to the nearest 10th